DFOSq conjugates bind antibodies irreversibly, preventing zirconium-89 detachment and reducing toxic side effects.
Albumin-binding moieties in folate conjugates reduce renal retention and radionephrotoxicity while enhancing tumor accumulation.
Tetrapyrrole compound with hydrogelator and cleavage site self-assembles into aggregates upon enzymatic trigger.
A ligand-SIFA conjugate links a fibroblast activation protein binder to a silicon-fluoride acceptor moiety.
I-124 labeled antibodies enable positron emission tomography tracking of intravitreal agents in non-human primate models.
Acetate buffer stabilizes PCTA-anti-EGFR antibody complexes, eliminating extemporaneous preparation costs and radiation exposure risks.
Labeling HER2 aptamers with 18F or fluorescent dyes enables in vivo imaging, resolving the trade-off between target specificity and detection capability.
Modified fibronectin domains achieve high specificity for PD-L1 expression, resolving the trade-off between imaging capability and detection accuracy.